CELLDEX THERAPEUTICS INC (CLDX) Stock Analyst Ratings
NASDAQ:CLDX - Nasdaq - US15117B2025 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to CLDX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 68.44. This target is 178.11% above the current price.
CLDX was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CLDX.
In the previous month the buy percentage consensus was at a similar level.
CLDX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-07 | Citigroup | Initiate | Buy |
| 2024-09-30 | Goldman Sachs | Initiate | Neutral |
| 2024-09-27 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-25 | Wolfe Research | Reiterate | Outperform -> Outperform |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-30 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-07-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-11 | Wolfe Research | Initiate | Outperform |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-27 | Guggenheim | Maintains | Buy -> Buy |
| 2023-12-20 | TD Cowen | Initiate | Outperform |
| 2023-11-10 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |